<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Araos R</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Diane Belfer Program for Human Microbial Ecology (M. J. B.)</funding><funding>Becas Chile, Comision Nacional de Investigacion Cientifica y Tecnologica</funding><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>, Gobierno de Chile</funding><pagination>937-943</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5019285</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63(7)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The emergence and dissemination of multidrug-resistant organisms (MDROs) is a global threat. Characterizing the human microbiome among hospitalized patients and identifying unique microbial signatures among those patients who acquire MDROs may identify novel infection prevention strategies.&lt;h4>Methods&lt;/h4>Adult patients admitted to 5 general medical-surgical floors at a 649-bed, tertiary care center in Boston, Massachusetts, were classified according to in-hospital antimicrobial exposure and MDRO colonization status. Within 48 hours of hospital admission (baseline) and at discharge (follow-up), rectal swab samples were obtained, and compared with samples from an external control group of healthy persons from the community. DNA was extracted from samples, next-generation </pubmed_abstract><journal>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</journal><pubmed_title>Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.</pubmed_title><pmcid>PMC5019285</pmcid><funding_grant_id>K24 AI119158</funding_grant_id><funding_grant_id>R01 DK090989</funding_grant_id><pubmed_authors>Tai AK</pubmed_authors><pubmed_authors>Blaser MJ</pubmed_authors><pubmed_authors>Snyder GM</pubmed_authors><pubmed_authors>Araos R</pubmed_authors><pubmed_authors>D'Agata EMC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.</name><description>&lt;h4>Background&lt;/h4>The emergence and dissemination of multidrug-resistant organisms (MDROs) is a global threat. Characterizing the human microbiome among hospitalized patients and identifying unique microbial signatures among those patients who acquire MDROs may identify novel infection prevention strategies.&lt;h4>Methods&lt;/h4>Adult patients admitted to 5 general medical-surgical floors at a 649-bed, tertiary care center in Boston, Massachusetts, were classified according to in-hospital antimicrobial exposure and MDRO colonization status. Within 48 hours of hospital admission (baseline) and at discharge (follow-up), rectal swab samples were obtained, and compared with samples from an external control group of healthy persons from the community. DNA was extracted from samples, next-generation </description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2026-07-15T23:57:44.241Z</modification><creation>2019-03-27T02:23:58Z</creation></dates><accession>S-EPMC5019285</accession><cross_references><pubmed>27358350</pubmed><doi>10.1093/cid/ciw426</doi></cross_references></HashMap>